AstraZeneca has agreed to initially supply at least 400 million doses of Oxford University's coronavirus vaccine and secured total manufacturing capacity to produce 1 billion doses.
The U.S. Biomedical Advanced Research and Development Authority has given AstraZeneca more than $1 billion in funding for the coronavirus vaccine.It announced a partnership with Oxford University in April to develop and distribute the vaccine.AstraZeneca
AstraZeneca's development program of the vaccine includes a phase three clinical trial with 30,000 participants and a pediatric trial. The University of Oxford announced it had partnered with AstraZeneca in April, to allow the drugmaker to develop and distribute the vaccine being researched by the Jenner Institute and Oxford Vaccine Group.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trialsAstraZeneca Plc said on Thursday it had received the first agreements to supply at least 400 million doses of the COVID-19 vaccine it is developing with the University of Oxford.
Lire la suite »
Op-Ed: How the COVID-19 pandemic has created dire legal problems for the poorThat's why Congress' new coronavirus relief measure needs to increase funding for free legal services by $1 billion.
Lire la suite »
U.S. Coronavirus Infection Surge ‘Yet To Materialize’ As People Resume Activity, Forecasters SayA University of Washington coronavirus model begins to track what happens as the U.S. reopens.
Lire la suite »
U.S. Coronavirus Infection Surge ‘Yet To Materialize’ As People Resume Activity, Forecasters SayAn anticipated surge in U.S. Covid-19 infections has “yet to materialize” despite increases in human mobility as states loosen restrictions, forecasters say by lisettevoytko
Lire la suite »